Prediction of treatment-induced changes in target-organ damage using changes in clinic, home and ambulatory blood pressure

Hypertension Research

Volumn 37, Issue 6, 2014, Pages 543-547

  Karpettas, Nikos ^a   Destounis, Antonis ^a   Kollias, Anastasios ^a   Nasothimiou, Efthimia ^a   Moyssakis, Ioannis ^b   Stergiou, George S ^a  

^a SOTIRIA GENERAL HOSPITAL   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

ambulatory blood pressure; home blood pressure; left ventricular hypertrophy; self measurement; target organ damage

Indexed keywords

AMLODIPINE; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; CARVEDILOL; HYDROCHLOROTHIAZIDE; IRBESARTAN; SPIRONOLACTONE; TELMISARTAN; VALSARTAN; ANTIHYPERTENSIVE AGENT;

ADD ON THERAPY; ADULT; ALBUMINURIA; AMBULATORY BLOOD PRESSURE; AMBULATORY CARE; AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CLINIC BLOOD PRESSURE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG DOSE TITRATION; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HOME BLOOD PRESSURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ORGAN INJURY; PREDICTION; PREDICTIVE VALUE; PULSE PRESSURE; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; TARGET ORGAN; TARGET ORGAN DAMAGE; TREATMENT DURATION; WAIST CIRCUMFERENCE; BLOOD PRESSURE MONITORING; COMPARATIVE STUDY; DRUG EFFECTS; ECHOGRAPHY; HEART VENTRICLE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; URINE;

ADULT; ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; HYPERTENSION; LINEAR MODELS; MALE; MIDDLE AGED; OFFICE VISITS; PREDICTIVE VALUE OF TESTS; PULSE WAVE ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84902000524     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2014.24     Document Type: Article

References (21)

1. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21: 821-848.
2. Bliziotis IA, Destounis A, Stergiou GS. Home versus ambulatory and office bloodpressure in predicting target organ damage in hypertension: a systematic review andmeta-analysis. J Hypertens 2012; 30: 1289-1299.
3. Stergiou GS, Siontis KC, Ioannidis JP. Home blood pressure as a cardiovascularoutcome predictor: it's time to take this method seriously. Hypertension 2010; 55:1301-1303.
4. Ward AM, Takahashi O, Stevens R, Heneghan C. Home measurement of blood pressureand cardiovascular disease: systematic review and meta-analysis of prospectivestudies. J Hypertens 2012; 30: 449-456.
5. O'Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, Fagard R, Graves J, Head G, Imai Y, Kario K, Lurbe E, Mallion JM, Mancia G, Mengden T, Myers M, Ogedegbe G, Ohkubo T, Omboni S, Palatini P, Redon J, Ruilope LM, Shennan A, Staessen JA, vanMontfrans G, Verdecchia P, Waeber B, Wang J, Zanchetti A, Zhang Y, on behalf of the European Society ofHypertension Working Group on Blood Pressure Monitoring. European Society ofHypertension position paper on ambulatory blood pressure monitoring. J Hypertens2013; 31: 1731-1768.
6. Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, Kario K, Lurbe E, Manolis A, Mengden T, O'Brien E, Ohkubo T, Padfield P, Palatini P, Pickering T, Redon J, Revera M, Ruilope LM, Shennan A, Staessen JA, Tisler A, Waeber B, Zanchetti A, Mancia G. European Society of Hypertension guidelines for blood pressuremonitoring at home: a summary report of the second international consensusconference on home blood pressure monitoring. J Hypertens 2008; 26: 1505-1526.
7. Stergiou GS, Bliziotis IA. Home blood pressure monitoring in the diagnosis andtreatment of hypertension: a systematic review. Am J Hypertens 2011; 24: 123-134.
8. Nasothimiou EG, Tzamouranis D, Rarra V, Roussias LG, Stergiou GS. Diagnosticaccuracy of home vs. ambulatory blood pressure monitoring in untreated and treatedhypertension. Hypertens Res 2012; 35: 750-755.
9. Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, De Cesaris R, Fogari R, Pessina A, Porcellati C, Rappelli A, Salvetti A, Trimarco B. Ambulatory blood pressure is superiorto clinic blood pressure in predicting treatment-induced regression of left ventricularhypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressureand Lisinopril Evaluation. Circulation 1997; 95: 1464-1470.
10. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B, Management of ArterialHypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for theManagement of Arterial Hypertension of the European Society of Hypertension and ofthe European Society of Cardiology. J Hypertens 2007; 25: 1105-1187.
11. Stergiou G, Karpettas N, Destounis A, Tzamouranis D, Nasothimiou E, Kollias A, Roussias L, Moyssakis I. Home blood pressure monitoring alone versus combined clinicand ambulatory measurements in following treatment induced changes in bloodpressure and organ damage. Am J Hypertens 2014; 27: 184-192.
12. Stergiou GS, Tzamouranis D, Protogerou A, Nasothimiou E, Kapralos C. Validation ofthe Microlife Watch BP Office professional device for office blood pressure measurementaccording to the International Protocol. Blood Press Monit 2008; 13: 299-303.
13. Stergiou GS, Giovas PP, Gkinos CP, Patouras JD. Validatin of the Microlife WatchBPHome device for self home blood pressure measurement according to the InternationalProtocol. Blood Press Monit 2007; 12: 185-188.
14. O'Brien E, Mee F, Atkins N, Halligan A, O'Malley K. Accuracy of the SpaceLabs 90207ambulatory blood pressure measuring system in normotensive pregnant womendetermined by the British Hypertension Society protocol. J Hypertens 1993; 11:S282-S283.
15. Ragazzo F, Saladini F, Palatini P. Validation of the Microlife WatchBP O3 device forclinic, home, and ambulatory blood pressure measurement, according to the InternationalProtocol. Blood Press Monit 2010; 15: 59-62.
16. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N.Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsyfindings. Am J Cardiol 1986; 57: 450-458.
17. Mosteller RD. Simplified calculation of body-surface area. New Engl J Med 1987;317: 1098.
18. Mattace-Raso F, Hofman A, Verwoert GC, Wittemana JC, Wilkinson I, Cockcroft J, McEniery C, Yasmin, Laurent S, Boutouyrie P, Bozec E, Hansen TW, Torp-Pedersen C, Ibsen H, Jeppesen J, Vermeersch SJ, Rietzschel E, De Buyzere M, Gillebert TC, Van Bortel L, Segers P, Vlachopoulos C, Aznaouridis C, Stefanadis C, Benetos A, Labat C, Lacolley P, Stehouwer C, Nijpels G, Dekker JM, Stehouwer C, Ferreira I, Twisk JW, Czernichow S, Galan P, Hercberg S, Pannier B, Gué rin A, London G, Cruickshank JK, Anderson SG, Paini A, Agabiti Rosei E, Muiesan ML, Salvetti M, Filipovsky J, Seidlerova J, Dolejsova M. Determinants of pulse wave velocity in healthypeople and in the presence of cardiovascular risk factors: establishing normal andreference values. Reference values for Arterial Stiffness' Collaboration. Eur Heart J2010; 31: 2338-2350.
19. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Task ForceMembers. 2013 ESH/ESC Guidelines for the management of arterial hypertension: theTask Force for the management of arterial hypertension of the European Society ofHypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens2013; 31: 1281-1357.
20. Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, Filipovsky J, Huybrechts S, Mattace-Raso FU, Protogerou AD, Schillaci G, Segers P, Vermeersch S, Weber T, Artery Society; European Society of Hypertension WorkingGroup on Vascular Structure and Function; European Network for NoninvasiveInvestigation of Large Arteries. Expert consensus document on the measurement ofaortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens2012; 30: 445-448.
21. Mancia G, Bombelli M, Brambilla G, Facchetti R, Sega R, Toso E, Grassi G. Long-termprognostic value of white coat hypertension: an insight from diagnostic use ofboth ambulatory and home blood pressure measurements. Hypertension 2013; 62:168-174.